United States· US:21586-011_425c90b3-5006-427e-95f6-93ee7918fb8b
Cefotaxime
A third-generation cephalosporins product containing cefotaxime injection, registered in United States by SteriMax Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- cefotaxime injection
- Manufacturer
- SteriMax Inc.
- Country
- United States (US)
- ATC code
- J01DD
- ATC class
- Third-generation cephalosporins
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 12, 2026
Packs & prices · 1
- ndc11215860110210 VIAL in 1 PACKAGE (21586-011-02) / 1 POWDER, FOR SOLUTION in 1 VIAL (21586-011-01)
Regulatory notes
Same medicine, other countries
Cefotaxime injection in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomCefotaxime 1g powder for solution for injection vialsBowmed Ibisqus Ltd
- FinlandCefotaxim AbbottAbbott Scandinavia AB
- CzechiaCEFOTAXIME HAMELNhameln pharma gmbh, Hameln
- SpainCEFOTAXIMA IPS 2 G POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE IV EFGI P S Farma S.L.
- ItalyBATIXIMSO.SE.PHARM S.R.L.
- GermanyCefotaxim EberthDr. Friedrich Eberth Arzneimittel Gmbh
- BelgiumCefotaxim Sandoz 1 gSandoz
- IrelandCefotaxime 1 g powder for solution for injection/infusionNoridem Enterprises Limited
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Cefotaxim Aptapharma, Cefotaxim Eberth
- Belgium · Cefotaxime Noridem, Claforan
- Bulgaria · Валоран, Тенатаксим
- Cyprus · Oximezin, Syntoxime
- Czechia · Cefotaxim Hameln, Cefotaxime Swyssi
- Germany · Cefotaxim Eberth, Cefotaxim Fresenius
- Denmark · Cefotaxim "hameln", Cefotaxim Mip
- Estonia · Cefotaxime Mip, Valoran
- Spain · Cefotaxima Normon, Cefotaxima Sala
- Finland · Cefotaxim Hameln, Cefotaxim Mip Pharma
- France · Cefotaxime Noridem, Cefotaxime Panpharma
- United Kingdom (Northern Ireland) · Cefotaxime Cox Pharmaceutical, Cefotaxime Hameln Pharma
- Greece · Ciltiren, Gloryfen
- Croatia · Cefotaksim Aptapharma, Cefotaksim Mip
- Hungary · Cefotaxim Aptapharma, Cefotaxime Swyssi
- Ireland · Cefotaxime Hameln, Cefotaxime Noridem Enterprises
- Iceland · Cefotaxim Navamedic
- Italy · Batixim, Cefotaxim Hameln
- Lithuania · Cefotaxime Mip
- Luxembourg · Cefotaxime Noridem, Claforan
- Latvia · Cefotaxime Mip
- Malta · Valoran
- Netherlands · Cefotaxim Hameln
- Norway · Cefotaxim Hameln, Cefotaxim Mip
- Poland · Biotaksym, Cefotaxim Mip
- Portugal · Antadar, Antadar I.M.
- Romania · Cefotax, Cefotaxim Mip
- Sweden · Cefotaxim Hameln, Cefotaxim Mip
- Slovenia · Cefotaksim Aptapharma, Valoran
- Slovakia · Cefotaxim Eberth, Cefotaxime Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/6fe375e1-d1d1-4712-891f-7cb5daeb9a6a GET /v1/drugs/6fe375e1-d1d1-4712-891f-7cb5daeb9a6a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"unii": {
"unii": "258J72S7TZ",
"rxcui": "203117",
"inchikey": "AZZMGZXNTDTSME-JUZDKLSSSA-M",
"display_name": "CEFOTAXIME SODIUM",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "INTRAMUSCULAR; INTRAVENOUS",
"livertox": {
"summary": null,
"livertox_id": null,
"hepatotoxicity_score": 4
},
"spl_meta": {
"8efe3bd0-c43a-2bd6-e053-2a95a90a92fa": {
"match": "brand_token",
"title": "CEFOTAXIME (CEFOTAXIME INJECTION) POWDER, FOR SOLUTION [STERIMAX INC.]",
"spl_version": "6",
"published_date": "2024-12-16"
}
},
"productid": "21586-011_425c90b3-5006-427e-95f6-93ee7918fb8b",
"productndc": "21586-011",
"dosage_form": "POWDER, FOR SOLUTION",
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "CEFOTAXIME SODIUM",
"shortage_reason": "Cefotaxime Sodium Powder, for Solution",
"shortage_status": "current",
"proprietary_name": "Cefotaxime",
"active_ingred_unit": "g/1",
"application_number": null,
"marketing_category": "UNAPPROVED DRUG FOR USE IN DRUG SHORTAGE",
"nonproprietary_name": "cefotaxime injection",
"start_marketing_date": "20190801",
"active_numerator_strength": "1"
}See everything about cefotaxime injection.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.